<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0002665'>Lymphoma</z:hpo> occurs at increased frequency in patients with the acquired <z:hpo ids='HP_0002721'>immunodeficiency</z:hpo> syndrome (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>) </plain></SENT>
<SENT sid="1" pm="."><plain>We studied, using serologic and molecular techniques, one such <z:hpo ids='HP_0002665'>lymphoma</z:hpo> for (a) evidence of <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with human T lymphotropic virus, type III (HTLV-III), and Epstein-Barr virus (EBV), (b) monoclonal rearrangement of immunoglobulin and T cell receptor genes, and (c) rearrangement of the c-myc oncogene </plain></SENT>
<SENT sid="2" pm="."><plain>Immunoglobulin and T cell receptor gene studies demonstrated that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> was of monoclonal B cell origin </plain></SENT>
<SENT sid="3" pm="."><plain>Similar to cases of Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> unrelated to <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AIDS</z:e>, there were DNA sequences in the <z:hpo ids='HP_0002665'>lymphoma</z:hpo> that hybridized to EBV-specific probes and demonstrated evidence of c-myc rearrangement </plain></SENT>
<SENT sid="4" pm="."><plain>HTLV-III sequences were not detected in the malignant B cells </plain></SENT>
<SENT sid="5" pm="."><plain>The pathogenesis of some B cell <z:hpo ids='HP_0002664'>neoplasms</z:hpo> in patients with the syndrome may involve transformation by EBV and deregulation of oncogene expression without <z:e sem="disease" ids="C1707758" disease_type="Disease or Syndrome" abbrv="">direct infection</z:e> of the malignant B cells by HTLV-III </plain></SENT>
</text></document>